Article info
Original research
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials
- Correspondence to Manu Vatish, Nuffield Department of Women’s & Reproductive Health, University of Oxford, Oxford, UK; manu.vatish{at}wrh.ox.ac.uk
Citation
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials
Publication history
- Received April 8, 2022
- Accepted September 9, 2022
- First published September 28, 2022.
Online issue publication
May 17, 2023
Article Versions
- Previous version (17 May 2023).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.